A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas

Trial Profile

A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Vismodegib (Primary)
  • Indications Chondrosarcoma
  • Focus Therapeutic Use
  • Acronyms CHONDROG; IB-CHONDROG
  • Most Recent Events

    • 25 Jul 2017 Planned primary completion date changed from 30 Jun 2016 to 30 Jun 2018.
    • 15 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 10 Jan 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Dec 2015 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top